ACW 3.85% 2.7¢ actinogen medical limited

EU regulators reject Leqembi for Alzheimers, page-21

  1. 34 Posts.
    lightbulb Created with Sketch. 5
    And since Xanadu there has literally been 2 other clinical trials report positive results, being Xanahes and the XanaMIA Part A dosing study and the biomarker study going back to stored samples for Xanadu which showed very interesting cognitive improvements in patients with high pTau levels.
    It is fine to reference the past as a cautionary tale, but if one tries to be rational and objective, Xanadu, like the movie, was a lifetime ago
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.